Profilo
Lisa Amaya Price is currently Chief Human Resources Officer at Disc Medicine, Inc. since 2026.
Formerly, Ms. Price was Chief Human Resources Officer & Senior VP at Deciphera Pharmaceuticals, Inc. from 2022 to 2026 and Chief People Officer at LGC Group, Inc. Education includes graduate studies at Simmons University, undergraduate studies at Bard College, and an MBA from F.W.
Olin Graduate School of Business.
Posizioni attive di Lisa Amaya Price
| Società | Posizione | Inizio |
|---|---|---|
| DISC MEDICINE, INC. | Ufficiale delle Risorse Umane | 12/01/2026 |
Precedenti posizioni note di Lisa Amaya Price
| Società | Posizione | Fine |
|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Ufficiale delle Risorse Umane | 01/01/2026 |
LGC Group, Inc.
LGC Group, Inc. Medical SpecialtiesHealth Technology Develops life science tools, components and solutions | Ufficiale delle Risorse Umane | - |
Formazione di Lisa Amaya Price
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Simmons University
Simmons University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bard College
Bard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
F.W. Olin Graduate School of Business
F.W. Olin Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deciphera Pharmaceuticals, Inc.
Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drug candidates to improve the lives of cancer patients | Health Technology |
LGC Group, Inc.
LGC Group, Inc. Medical SpecialtiesHealth Technology Develops life science tools, components and solutions | Health Technology |
Disc Medicine, Inc.
Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
















